Delivery Order SPE2DB24D3014-SPE2DB25FKTLL
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Colestipol HCL 1 GM Tablets. The contract has a ceiling value of $4,411.65 and a period of performance through May 9, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,566,053,970 tablets of Colestipol HCl 1 g. The contract is a firm-fixed-price delivery order with a ceiling value of $2,941.44 and a period of performance through October 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Colestipol HCL 1 GM Tablets, a medication used to treat high cholesterol. The contract has a firm fixed price and a ceiling value of $4,058.54. It was awarded on May 7, 2025, with a final completion date of May 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol Hydrochloride 1 gram tablets, a medication used to treat high cholesterol. The contract has a ceiling value of $2,250.86 and is a firm fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside and was awarded on April...
This federal contract award, with ID SPE2DB24D1107|SPE2DB25FZFD2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,221.86 firm fixed-price delivery order is for the supply of 4,568,092,834 tablets of Colestipol HCL 1 GM, a medication used to treat high cholesterol. The contract has an ultimate completion date of May 1, 2025 and was awarded on April 30, 2025. This award is not designated...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,065.94 Firm Fixed Price Delivery Order is for the supply of 120 tablets of Colestipol HCL 1 GM, a medication used to treat high cholesterol. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive...
The federal contract award is for the delivery of COLESEVELAM HCL 3.75 G PACKET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $9,801.38, and has an ultimate completion date of February 12, 2025. The contract was not designated with a set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price ceiling value of $19,770.96 and a performance period extending through May 13, 2025. The contract is not set aside and involves the delivery of a variety of pharmaceutical products and medical supplies to support federal government agencies, including the Defense Health...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of a variety of pharmaceutical products and medical supplies. The contract has a ceiling value of $32,142.24 and an ultimate completion date of May 16, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed-price delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,815.81 and a performance period extending through May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...